|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
decreases expression |
EXP |
acenaphthylene results in decreased expression of CXCL8 mRNA |
CTD |
PMID:23724284 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression |
ISO |
acenaphthylene results in increased expression of CYP1A1 mRNA; acenaphthylene results in increased expression of CYP1A1 protein |
CTD |
PMID:10190573 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
increases expression increases oxidation multiple interactions increases activity |
ISO EXP |
acenaphthylene results in increased expression of CYP1A2 mRNA; acenaphthylene results in increased expression of CYP1A2 protein CYP1A2 protein results in increased oxidation of acenaphthylene [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA acenaphthylene results in increased activity of CYP1A2 protein |
CTD |
PMID:7750161 PMID:8001243 PMID:10977129 PMID:25642975 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
increases expression increases oxidation |
ISO EXP |
acenaphthylene results in increased expression of CYP1B1 mRNA CYP1B1 protein results in increased oxidation of acenaphthylene |
CTD |
PMID:10402558 PMID:25642975 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP2A13 |
cytochrome P450 family 2 subfamily A member 13 |
increases oxidation |
EXP |
CYP2A13 protein results in increased oxidation of acenaphthylene; CYP2A13 protein results in increased oxidation of acenaphthylene metabolite |
CTD |
PMID:25642975 |
|
NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
increases oxidation |
EXP |
CYP2A6 protein results in increased oxidation of acenaphthylene; CYP2A6 protein results in increased oxidation of acenaphthylene metabolite |
CTD |
PMID:25642975 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2C9 |
cytochrome P450 family 2 subfamily C member 9 |
increases oxidation |
EXP |
CYP2C9 protein results in increased oxidation of acenaphthylene |
CTD |
PMID:25642975 |
|
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
increases oxidation |
EXP |
CYP3A4 protein results in increased oxidation of acenaphthylene |
CTD |
PMID:25642975 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage |
EXP |
acenaphthylene results in increased cleavage of PARP1 protein |
CTD |
PMID:21132278 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|